Micro and nanocrystalline cellulose based oral dispersible film; preparation and evaluation of in vitro/in vivo rapid release studies for donepezil

Oral fast-dispersible film was prepared by utlizing donepezil hydrochloride (drug) and various cellulose derivatives such as hydroxypropyl methyl cellulose (hypermellose) (HPMC), microcrystalline cellulose (MCC) and nanocrystalline cellulose (NCC) to treat Alzheimer's disease. NCC was synthesiz...

Full description

Saved in:
Bibliographic Details
Main Authors: Keshireddy AnjiReddy (Author), Subramanian Karpagam (Author)
Format: Book
Published: Universidade de São Paulo, 2020-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_ba8c7b24d0e341e8b09c94c5df5cb3eb
042 |a dc 
100 1 0 |a Keshireddy AnjiReddy  |e author 
700 1 0 |a Subramanian Karpagam  |e author 
245 0 0 |a Micro and nanocrystalline cellulose based oral dispersible film; preparation and evaluation of in vitro/in vivo rapid release studies for donepezil 
260 |b Universidade de São Paulo,   |c 2020-11-01T00:00:00Z. 
500 |a 2175-9790 
500 |a 10.1590/s2175-97902020000117797 
520 |a Oral fast-dispersible film was prepared by utlizing donepezil hydrochloride (drug) and various cellulose derivatives such as hydroxypropyl methyl cellulose (hypermellose) (HPMC), microcrystalline cellulose (MCC) and nanocrystalline cellulose (NCC) to treat Alzheimer's disease. NCC was synthesized by ultra-sonication method using MCC and this was converted to thinfilm formulation (NCC-F) using solvent casting technique. The interaction between the polymer and the drug was investigated by spectral analysis such as UV, FTIR, and 1H- NMR. FTIR confirmed that the compatibility of drug and polymer in ODF formulation. NCC-F has shown an average surface roughness of 77.04 nm from AFM and the average particle size of 300 nm from SEM analysis. Nano sized particle of NCC-F leads faster in vitro dissolution rate (94.53%) when compared with MCC-F and F3 formulation. Animal model (in vivo) studies of NCC-F formulation has reached peak plasma concentration (Cmax) up to 19.018 ng/mL in the span of (tmax) 4 h with greater relative bioavailability of 143.1%. These results suggested that high surface roughness with nanosized NCC-F formulation attained extended drug availability up to (t1/2) 70 h. 
546 |a EN 
690 |a Oral dispersible film 
690 |a Nanocrystalline cellulose 
690 |a Ultrasonication 
690 |a 3D atomic force microscopy 
690 |a Donepezil 
690 |a Solvent casting 
690 |a Alzheimer's disease 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Brazilian Journal of Pharmaceutical Sciences, Vol 56 (2020) 
787 0 |n http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502020000100586&tlng=en 
787 0 |n https://doaj.org/toc/2175-9790 
856 4 1 |u https://doaj.org/article/ba8c7b24d0e341e8b09c94c5df5cb3eb  |z Connect to this object online.